Form D — Neuvivo, Inc.
0001104659-26-127191 · filed Nov 13, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $9,500,000
- Reported amount sold
- $1,384,615
- Minimum investment
- $0
- Investors
- 1
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Neuvivo, Inc.
- CIK
- 2154992
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2100 GENG ROAD
PALO ALTO, California 94303 - Phone
- (650) 440-6766
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michael McGrath · Executive OfficerPalo Alto, California Find on LinkedIn ↗
-
Virit Vichitvadakan · DirectorPalo Alto, California Find on LinkedIn ↗
-
Pornsit Poovanakijjakorn · DirectorPalo Alto, California Find on LinkedIn ↗
-
Robert Baffi · DirectorPalo Alto, California Find on LinkedIn ↗
-
John Curnutte · DirectorPalo Alto, California Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗